Co-Chair

Matt Galsky

MD
Professor of Medicine
Icahn School of Medicine at Mount Sinai

Dr. Galsky is Professor of Medicine (Hematology and Medical Oncology), Director of Genitourinary Medical Oncology, Co-Director of the Center of Excellence for Bladder Cancer at The Tisch Cancer Institute, and Associate Director for Translational Research at The Tisch Cancer Institute. Dr. Galsky specializes in the care of patients with genitourinary malignancies—bladder, prostate, kidney, and testicular cancers. His research centers on team science-based approaches to dissecting the mechanistic underpinnings of response and resistance to novel bladder cancer therapies.

2026 Sessions

Selected Topic in Genitourinary Cancer

  • Moderator
    • Matt Galsky
Genitourinary Cancers

First-Line Strategies in Metastatic Renal Cancer: Doublet Immune Checkpoint Blockade vs Immune Checkpoint Blockade Plus VEGFR TKI

  • Moderator
    • Matt Galsky
  • Presenter
    • Stephanie Berg
    • Eric Miller
Genitourinary Cancers

Optimizing Immunotherapy Strategies in Muscle-Invasive Bladder Cancer: Neoadjuvant IO-Containing Systemic Therapy vs Risk-Adapted Adjuvant IO

  • Moderator
    • Matt Galsky
  • Presenter
    • David Aggen
    • Rohit Jain
Genitourinary Cancers

Using Lutetium-PSMA in Metastatic Prostate Cancer: Early vs Later Use

  • Moderator
    • Matt Galsky
  • Presenter
    • Atish Choudhury
    • Scott Tagawa
Genitourinary Cancers
Back to top